News Topic: Eye Health

Essilor Steps Up Sun Protection Initiative With 10-Year Licensing Agreement for Safilo’s Polaroid Branded Ophthalmic Lenses
5/2013
CHARENTON-LE-PONT, France and PADUA, Italy— Essilor (ESSI:PA) and Safilo (SFL:BrsaItaliana) have signed a 10-year licensing agreement for the design, manufacture and worldwide distribution by Essilor More »
agreement, Essilor, Hubert Sagnieres, initiative, lenses, license, licensing, polarized, Polaroid, Roberto Vedovotto, Safilo, uv

Results of Study Examining Unoprostone for Retinitis Pigmentosa Announced
5/2013
At the recent Association for Research in Vision and Ophthalmology meeting, results of a study on R-Tech Ueno's unoprostone (development code UF-021) for retinitis pigmentosa were announced. More »
retina, retinitis pigmentosa, UF-021, unoprostone

Essilor Launches New Crizal Consumer Ad Campaign
5/2013
DALLAS— Essilor of America is launching a national advertising campaign that talks directly to consumers about the benefits of Crizal No-Glare lenses. More »
ad, advertising, Campaign, consumers, Crizal, E-SPF, Essilor, lenses, multimedia, uv

Industry Gears Up for Optometry’s Meeting in June
5/2013
SAN DIEGO—The American Optometric Association will hold its 116th Annual AOA Congress & 43rd Annual AOSA Conference, known as Optometry’s Meeting, at the Convention Center here from June 26 to 30. More »
American Optometric Association, AOA, AOSA Conference, conference, Education, Essilor, exhibits, networking, optometrist, Optometry's Meeting, staff, student

Arthritis Drug Dampens Dry Eye
5/2013
Topical application of the rheumatoid arthritis drug Kineret (anakinra, Amgen) effectively treats the symptoms of dry eye disease, according to a study in the April 18 online edition of JAMA Ophthalmo More »
Amgen, anakinra, dry eye disease, Kineret, meibomian gland dysfunction, rheumatoid arthritis

World's First Patient Treated With Commercially Available Iluvien

5/2013
Alimera Sciences Inc. reported that Albert J. More »
Albert J. Augustin MD, Alimera Sciences Inc., diabetic macular edema, DME, Iluvien, implant injection

Confirmatory Phase III Clinical Study of BromSite Initiated
5/2013
Patient enrollment has begun in the confirmatory Phase III clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain following cataract surgery. More »
BromSite, cataract surgery, clinical trial, DuraSite, InSite Vision, ISV-303

Data Presented on Novel Topical Treatment for Dry Eye Disease
5/2013
Eleven Biotherapeutics recently presented data for EBI-005, the first interleukin-1 (IL-1) signaling inhibitor designed for topical ocular administration. More »
clinical study, dry eye, dry eye disease, EBI-005, Eleven Biotherapeutics, interleukin-1 signaling inhibitor, ocular surface inflammatory disease

New Report by The Vision Council Examines Gaps in UV Safety
5/2013
ALEXANDRIA—Despite the damaging effects of ultraviolet radiation (UV) to eyes and vision, 40 percent of U.S. More »
damage, protection, radiation, Report, sunglasses, The Vision Council, ultraviolet, uv, VIsion Council

Investigational New Drug Application Approved for Dry Eye Treatment
5/2013
R-Tech Ueno is developing a recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) for the treatment of severe dry eye. More »
clinical trials, dry eye, FDA approval, RU-101

1 of 56

Copyright © 2010 Jobson Medical Information LLC. All Rights Reserved.